Literature DB >> 19498341

Racial differences in blood pressure response to calcium channel blocker monotherapy: a meta-analysis.

Thu T Nguyen1, Jay S Kaufman, Eric A Whitsel, Richard S Cooper.   

Abstract

BACKGROUND: A systematic literature review was conducted to determine whether US blacks and whites have differential blood pressure (BP) response to calcium channel blocker (CCB) monotherapy.
METHODS: Six published studies made up the final cohort of eligible articles. Multiple treatment groups within some studies led to a total of eight sets of estimates for BP reduction with a total of 6,851 white or nonblack participants and 3,371 black participants.
RESULTS: The pooled difference in systolic blood pressure (SBP) change between blacks and whites was -2.7 mm Hg (95% confidence interval (CI): -4.0, -1.3) with blacks having greater response. The difference in diastolic blood pressure (DBP) between blacks and whites was -0.4 mm Hg (95% CI: -1.0, 0.3) with blacks having greater response. Using a dichotomous outcome measure, whites were found to be just as likely as blacks to attain the DBP goal of <90 mm Hg or a 10 mm Hg or greater change (relative risk: 1.00 95% CI: 0.91, 1.11). In addition, examination of the continuous distribution of BP responses of whites and blacks showed over 90% overlap in treatment response.
CONCLUSION: Assessment of differential response to CCB monotherapy by race in published data depends on choice of outcome metric. Nonetheless, the results of this systematic review indicate that BP response is qualitatively similar in US blacks and whites, suggesting that patient race is not likely to offer any clinical utility for decisions about the likely effect of this antihypertensive therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19498341      PMCID: PMC6414055          DOI: 10.1038/ajh.2009.100

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  28 in total

1.  Commentary: considerations for use of racial/ethnic classification in etiologic research.

Authors:  J S Kaufman; R S Cooper
Journal:  Am J Epidemiol       Date:  2001-08-15       Impact factor: 4.897

2.  Racial differences in the response to drugs--pointers to genetic differences.

Authors:  A J Wood
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

3.  Overlap between whites and blacks in response to antihypertensive drugs.

Authors:  Ashwini R Sehgal
Journal:  Hypertension       Date:  2004-02-02       Impact factor: 10.190

4.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Authors:  Jackson T Wright; George Bakris; Tom Greene; Larry Y Agodoa; Lawrence J Appel; Jeanne Charleston; DeAnna Cheek; Janice G Douglas-Baltimore; Jennifer Gassman; Richard Glassock; Lee Hebert; Kenneth Jamerson; Julia Lewis; Robert A Phillips; Robert D Toto; John P Middleton; Stephen G Rostand
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

Review 5.  Why is plasma renin activity lower in populations of African origin?

Authors:  G A Sagnella
Journal:  J Hum Hypertens       Date:  2001-01       Impact factor: 3.012

6.  Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction.

Authors:  D V Exner; D L Dries; M J Domanski; J N Cohn
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

7.  A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

Authors:  Carl J Pepine; Eileen M Handberg; Rhonda M Cooper-DeHoff; Ronald G Marks; Peter Kowey; Franz H Messerli; Giuseppe Mancia; José L Cangiano; David Garcia-Barreto; Matyas Keltai; Serap Erdine; Heather A Bristol; H Robert Kolb; George L Bakris; Jerome D Cohen; William W Parmley
Journal:  JAMA       Date:  2003-12-03       Impact factor: 56.272

8.  Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

Authors:  B Williams; N R Poulter; M J Brown; M Davis; G T McInnes; J F Potter; P S Sever; S McG Thom
Journal:  J Hum Hypertens       Date:  2004-03       Impact factor: 3.012

9.  Comparison of the efficacy and tolerability of Prinivil and Procardia XL in black and white hypertensive patients.

Authors:  M R Weir; P T Lavin
Journal:  Clin Ther       Date:  1992 Sep-Oct       Impact factor: 3.393

10.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

View more
  5 in total

1.  Pharmacogenetics in primary care: the promise of personalized medicine and the reality of racial profiling.

Authors:  Linda M Hunt; Meta J Kreiner
Journal:  Cult Med Psychiatry       Date:  2013-03

2.  24-Hour ambulatory blood pressure response to combination valsartan/hydrochlorothiazide and amlodipine/hydrochlorothiazide in stage 2 hypertension by ethnicity: the EVALUATE study.

Authors:  Jackson T Wright; Yves Lacourcière; Rita Samuel; Dion Zappe; Das Purkayastha; Henry R Black
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-09-24       Impact factor: 3.738

3.  Antihypertensive Medication Use and Its Effects on Blood Pressure and Haemodynamics in a Tri-ethnic Population Cohort: Southall and Brent Revisited (SABRE).

Authors:  Alun D Hughes; Sophie V Eastwood; Therese Tillin; Nish Chaturvedi
Journal:  Front Cardiovasc Med       Date:  2022-01-14

4.  Association of West African ancestry and blood pressure control among African Americans taking antihypertensive medication in the Jackson Heart Study.

Authors:  Jon C Van Tassell; Daichi Shimbo; Rachel Hess; Rick Kittles; James G Wilson; Lynn B Jorde; Man Li; Leslie A Lange; Ethan M Lange; Paul Muntner; Adam P Bress
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-02-12       Impact factor: 3.738

Review 5.  Lercanidipine in the Management of Hypertension: An Update.

Authors:  Guido Grassi; Nicolàs R Robles; Gino Seravalle; Francesco Fici
Journal:  J Pharmacol Pharmacother       Date:  2017 Oct-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.